Jefferies Liftas PT on Celgene (CELG) to $114 Post Q4

Go back to Jefferies Liftas PT on Celgene (CELG) to $114 Post Q4

Celgene Corp (CELG) Tops Q4 EPS by 1c

January 24, 2013 7:32 AM EST

Celgene Corp (NASDAQ: CELG) reported Q4 EPS of $1.32, $0.01 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.45 billion.

For earnings history and earnings-related data on Celgene Corp (CELG) click here.... More